Track which hedge funds hold BIOCRYST PHARMACEUTICALS INC and how their positions changed over time.
Current Holders
135
Showing
5
| $173.7M |
| 0.0% |
31 |
| BlackRock, Inc. | 2025-Q4 | Decreased | 21.1M | -0.5% | $164.9M | 0.0% | 0 |
| RA CAPITAL MANAGEMENT, L.P. | 2025-Q4 | New | 15.8M | — | $123.5M | 1.3% | 69 |
| STATE STREET CORP | 2025-Q4 | Increased | 11.1M | +12.9% | $86.4M | 0.0% | 34 |
| JANUS HENDERSON GROUP PLC | 2025-Q4 | Increased | 7.4M | +7807.2% | $57.8M | 0.0% | 47 |
Showing 5 of 135 results.PROUpgrade to see all → |
Upgrade to Pro for 2 years of historical data, full analytics access, and CSV exports
Starting at $16/mo billed annually